109 related articles for article (PubMed ID: 12502983)
21. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia.
Caldwell JE; Heier T; Kitts JB; Lynam DP; Fahey MR; Miller RD
Br J Anaesth; 1989 Oct; 63(4):393-9. PubMed ID: 2530998
[TBL] [Abstract][Full Text] [Related]
23. Neuromuscular blockade of atracurium in permissive hypercapnic versus normocapnic swine undergoing laparoscopy.
Bellini L; De Benedictis GM
PLoS One; 2018; 13(7):e0200439. PubMed ID: 29979782
[TBL] [Abstract][Full Text] [Related]
24. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
[TBL] [Abstract][Full Text] [Related]
25. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity.
Cardone C; Szenohradszky J; Yost S; Bickler PE
Anesthesiology; 1994 May; 80(5):1155-61; discussion 29A. PubMed ID: 7912481
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
Jonsson Fagerlund M; Dabrowski M; Eriksson LI
Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
[TBL] [Abstract][Full Text] [Related]
27. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.
Nigrovic V; Gaspari J; Banoub M
Eur J Clin Pharmacol; 1996; 49(4):325-32. PubMed ID: 8857080
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
Boyd AH; Eastwood NB; Parker CJ; Hunter JM
Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
[TBL] [Abstract][Full Text] [Related]
29. In vitro neuromuscular effects of valproic acid.
Nguyen A; Ramzan I
Br J Anaesth; 1997 Feb; 78(2):197-200. PubMed ID: 9068341
[TBL] [Abstract][Full Text] [Related]
30. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
[TBL] [Abstract][Full Text] [Related]
31. The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants.
Wang H; Zhang Y; Li ST
Eur J Pharmacol; 2010 Mar; 630(1-3):29-33. PubMed ID: 20045405
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
Nathan N; Bonada G; Feiss P
Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
[TBL] [Abstract][Full Text] [Related]
33. Enhancement by cimetidine of neuromuscular paralysis induced with atracurium in rats.
Mishra Y; Ramzan I
Arch Int Pharmacodyn Ther; 1992; 318():97-106. PubMed ID: 1463374
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine.
Blobner M; Kochs E; Fink H; Mayer B; Veihelmann A; Brill T; Stadler J
Anesthesiology; 1999 Oct; 91(4):999-1005. PubMed ID: 10519503
[TBL] [Abstract][Full Text] [Related]
35. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans.
Rupp SM; McChristian JW; Miller RD
Anesthesiology; 1985 Jul; 63(1):16-9. PubMed ID: 3160265
[TBL] [Abstract][Full Text] [Related]
36. Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease.
Soltész S; Mencke T; Mey C; Röhrig S; Diefenbach C; Molter GP
Br J Anaesth; 2008 Jun; 100(6):798-802. PubMed ID: 18400809
[TBL] [Abstract][Full Text] [Related]
37. Neuromuscular blocking drug pharmacodynamics after chronic exposure to H2- antagonists.
Rana J; Ramzan I
In Vivo; 1995; 9(2):163-6. PubMed ID: 7548793
[TBL] [Abstract][Full Text] [Related]
38. Increased sensitivity to depolarization and nondepolarizing neuromuscular blocking agents in young rat hemidiaphragms.
Fortier LP; Robitaille R; Donati F
Anesthesiology; 2001 Aug; 95(2):478-84. PubMed ID: 11506123
[TBL] [Abstract][Full Text] [Related]
39. [Cisatricurium in the orbicularis oculi muscle. Comparisn of the neuromuscular action of cisatracurium and atracurium in the orbicularis oculi muscle and the adductor pollicis muscle].
de Rossi L; Fritz H; Kröber L; Klein U
Anaesthesist; 1999 Sep; 48(9):602-6. PubMed ID: 10525592
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat model of neuromyopathy.
Liu L; Min S; Li W; Wei K; Luo J; Wu G; Ao L; Cao J; Wang B; Wang Z
Br J Anaesth; 2014 Jan; 112(1):159-68. PubMed ID: 23903895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
